nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Feeling abnormal—Bleomycin—testicular cancer	0.00341	0.00341	CcSEcCtD
Pindolol—Hot flush—Epirubicin—testicular cancer	0.00341	0.00341	CcSEcCtD
Pindolol—Vomiting—Chlorambucil—testicular cancer	0.0034	0.0034	CcSEcCtD
Pindolol—Menopausal symptoms—Epirubicin—testicular cancer	0.00338	0.00338	CcSEcCtD
Pindolol—Diarrhoea—Vinblastine—testicular cancer	0.00336	0.00336	CcSEcCtD
Pindolol—Fatigue—Dactinomycin—testicular cancer	0.00333	0.00333	CcSEcCtD
Pindolol—Hypotension—Ifosfamide—testicular cancer	0.00331	0.00331	CcSEcCtD
Pindolol—Pain—Dactinomycin—testicular cancer	0.0033	0.0033	CcSEcCtD
Pindolol—Muscle spasms—Etoposide—testicular cancer	0.00329	0.00329	CcSEcCtD
Pindolol—Cardiac failure—Epirubicin—testicular cancer	0.00327	0.00327	CcSEcCtD
Pindolol—Lethargy—Epirubicin—testicular cancer	0.00325	0.00325	CcSEcCtD
Pindolol—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00325	0.00325	CcSEcCtD
Pindolol—Dizziness—Vinblastine—testicular cancer	0.00324	0.00324	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00323	0.00323	CcSEcCtD
Pindolol—Myalgia—Cisplatin—testicular cancer	0.00318	0.00318	CcSEcCtD
Pindolol—Feeling abnormal—Dactinomycin—testicular cancer	0.00318	0.00318	CcSEcCtD
Pindolol—Nausea—Chlorambucil—testicular cancer	0.00318	0.00318	CcSEcCtD
Pindolol—Paraesthesia—Ifosfamide—testicular cancer	0.00318	0.00318	CcSEcCtD
Pindolol—Anxiety—Cisplatin—testicular cancer	0.00317	0.00317	CcSEcCtD
Pindolol—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00316	0.00316	CcSEcCtD
Pindolol—Dyspnoea—Ifosfamide—testicular cancer	0.00316	0.00316	CcSEcCtD
Pindolol—Hot flush—Doxorubicin—testicular cancer	0.00315	0.00315	CcSEcCtD
Pindolol—Somnolence—Ifosfamide—testicular cancer	0.00315	0.00315	CcSEcCtD
Pindolol—Menopausal symptoms—Doxorubicin—testicular cancer	0.00313	0.00313	CcSEcCtD
Pindolol—Vomiting—Vinblastine—testicular cancer	0.00312	0.00312	CcSEcCtD
Pindolol—Vertigo—Etoposide—testicular cancer	0.00308	0.00308	CcSEcCtD
Pindolol—Headache—Vinblastine—testicular cancer	0.00307	0.00307	CcSEcCtD
Pindolol—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00306	0.00306	CcSEcCtD
Pindolol—Abdominal pain—Dactinomycin—testicular cancer	0.00305	0.00305	CcSEcCtD
Pindolol—Fatigue—Ifosfamide—testicular cancer	0.00305	0.00305	CcSEcCtD
Pindolol—Oedema—Cisplatin—testicular cancer	0.00305	0.00305	CcSEcCtD
Pindolol—Pain—Ifosfamide—testicular cancer	0.00303	0.00303	CcSEcCtD
Pindolol—Constipation—Ifosfamide—testicular cancer	0.00303	0.00303	CcSEcCtD
Pindolol—Cardiac failure—Doxorubicin—testicular cancer	0.00302	0.00302	CcSEcCtD
Pindolol—Loss of consciousness—Etoposide—testicular cancer	0.00301	0.00301	CcSEcCtD
Pindolol—Lethargy—Doxorubicin—testicular cancer	0.00301	0.00301	CcSEcCtD
Pindolol—Nervous system disorder—Cisplatin—testicular cancer	0.00299	0.00299	CcSEcCtD
Pindolol—Tachycardia—Cisplatin—testicular cancer	0.00298	0.00298	CcSEcCtD
Pindolol—Asthenia—Bleomycin—testicular cancer	0.00297	0.00297	CcSEcCtD
Pindolol—Hyperhidrosis—Cisplatin—testicular cancer	0.00295	0.00295	CcSEcCtD
Pindolol—Pruritus—Bleomycin—testicular cancer	0.00293	0.00293	CcSEcCtD
Pindolol—Feeling abnormal—Ifosfamide—testicular cancer	0.00292	0.00292	CcSEcCtD
Pindolol—Chest pain—Etoposide—testicular cancer	0.00292	0.00292	CcSEcCtD
Pindolol—Nausea—Vinblastine—testicular cancer	0.00291	0.00291	CcSEcCtD
Pindolol—Orthostatic hypotension—Epirubicin—testicular cancer	0.00291	0.00291	CcSEcCtD
Pindolol—Gastrointestinal pain—Ifosfamide—testicular cancer	0.0029	0.0029	CcSEcCtD
Pindolol—Hypotension—Cisplatin—testicular cancer	0.00285	0.00285	CcSEcCtD
Pindolol—Abdominal discomfort—Methotrexate—testicular cancer	0.00282	0.00282	CcSEcCtD
Pindolol—Confusional state—Etoposide—testicular cancer	0.00282	0.00282	CcSEcCtD
Pindolol—Abdominal pain—Ifosfamide—testicular cancer	0.0028	0.0028	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00278	0.00278	CcSEcCtD
Pindolol—Asthenia—Dactinomycin—testicular cancer	0.00277	0.00277	CcSEcCtD
Pindolol—Paraesthesia—Cisplatin—testicular cancer	0.00274	0.00274	CcSEcCtD
Pindolol—Tachycardia—Etoposide—testicular cancer	0.00273	0.00273	CcSEcCtD
Pindolol—Dyspnoea—Cisplatin—testicular cancer	0.00272	0.00272	CcSEcCtD
Pindolol—Erectile dysfunction—Methotrexate—testicular cancer	0.00271	0.00271	CcSEcCtD
Pindolol—Hyperhidrosis—Etoposide—testicular cancer	0.0027	0.0027	CcSEcCtD
Pindolol—Orthostatic hypotension—Doxorubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Pindolol—Diarrhoea—Dactinomycin—testicular cancer	0.00264	0.00264	CcSEcCtD
Pindolol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00264	0.00264	CcSEcCtD
Pindolol—Vomiting—Bleomycin—testicular cancer	0.00263	0.00263	CcSEcCtD
Pindolol—Drowsiness—Methotrexate—testicular cancer	0.00263	0.00263	CcSEcCtD
Pindolol—Depression—Methotrexate—testicular cancer	0.00262	0.00262	CcSEcCtD
Pindolol—Hypotension—Etoposide—testicular cancer	0.00261	0.00261	CcSEcCtD
Pindolol—Rash—Bleomycin—testicular cancer	0.00261	0.00261	CcSEcCtD
Pindolol—Pain—Cisplatin—testicular cancer	0.00261	0.00261	CcSEcCtD
Pindolol—Dermatitis—Bleomycin—testicular cancer	0.00261	0.00261	CcSEcCtD
Pindolol—Conjunctivitis—Methotrexate—testicular cancer	0.00255	0.00255	CcSEcCtD
Pindolol—Pollakiuria—Epirubicin—testicular cancer	0.00255	0.00255	CcSEcCtD
Pindolol—Asthenia—Ifosfamide—testicular cancer	0.00254	0.00254	CcSEcCtD
Pindolol—Sweating—Methotrexate—testicular cancer	0.00252	0.00252	CcSEcCtD
Pindolol—Feeling abnormal—Cisplatin—testicular cancer	0.00252	0.00252	CcSEcCtD
Pindolol—Paraesthesia—Etoposide—testicular cancer	0.00251	0.00251	CcSEcCtD
Pindolol—Weight increased—Epirubicin—testicular cancer	0.00251	0.00251	CcSEcCtD
Pindolol—Pruritus—Ifosfamide—testicular cancer	0.00251	0.00251	CcSEcCtD
Pindolol—Dyspnoea—Etoposide—testicular cancer	0.00249	0.00249	CcSEcCtD
Pindolol—Somnolence—Etoposide—testicular cancer	0.00249	0.00249	CcSEcCtD
Pindolol—Nausea—Bleomycin—testicular cancer	0.00246	0.00246	CcSEcCtD
Pindolol—Drowsiness—Epirubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Pindolol—Vomiting—Dactinomycin—testicular cancer	0.00246	0.00246	CcSEcCtD
Pindolol—Rash—Dactinomycin—testicular cancer	0.00244	0.00244	CcSEcCtD
Pindolol—Diarrhoea—Ifosfamide—testicular cancer	0.00242	0.00242	CcSEcCtD
Pindolol—Gastrointestinal disorder—Etoposide—testicular cancer	0.00241	0.00241	CcSEcCtD
Pindolol—Fatigue—Etoposide—testicular cancer	0.00241	0.00241	CcSEcCtD
Pindolol—Pain—Etoposide—testicular cancer	0.00239	0.00239	CcSEcCtD
Pindolol—Constipation—Etoposide—testicular cancer	0.00239	0.00239	CcSEcCtD
Pindolol—Conjunctivitis—Epirubicin—testicular cancer	0.00239	0.00239	CcSEcCtD
Pindolol—Sweating—Epirubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Pindolol—Dizziness—Ifosfamide—testicular cancer	0.00234	0.00234	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—testicular cancer	0.00232	0.00232	CcSEcCtD
Pindolol—Feeling abnormal—Etoposide—testicular cancer	0.0023	0.0023	CcSEcCtD
Pindolol—Nausea—Dactinomycin—testicular cancer	0.0023	0.0023	CcSEcCtD
Pindolol—Gastrointestinal pain—Etoposide—testicular cancer	0.00229	0.00229	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Pindolol—Visual impairment—Methotrexate—testicular cancer	0.00227	0.00227	CcSEcCtD
Pindolol—Vomiting—Ifosfamide—testicular cancer	0.00225	0.00225	CcSEcCtD
Pindolol—Bradycardia—Epirubicin—testicular cancer	0.00225	0.00225	CcSEcCtD
Pindolol—Rash—Ifosfamide—testicular cancer	0.00223	0.00223	CcSEcCtD
Pindolol—Dermatitis—Ifosfamide—testicular cancer	0.00223	0.00223	CcSEcCtD
Pindolol—Abdominal pain—Etoposide—testicular cancer	0.00221	0.00221	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—testicular cancer	0.00221	0.00221	CcSEcCtD
Pindolol—Tinnitus—Methotrexate—testicular cancer	0.0022	0.0022	CcSEcCtD
Pindolol—Asthenia—Cisplatin—testicular cancer	0.00219	0.00219	CcSEcCtD
Pindolol—Cardiac disorder—Methotrexate—testicular cancer	0.00219	0.00219	CcSEcCtD
Pindolol—Sweating—Doxorubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—testicular cancer	0.00214	0.00214	CcSEcCtD
Pindolol—Visual impairment—Epirubicin—testicular cancer	0.00213	0.00213	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—testicular cancer	0.00213	0.00213	CcSEcCtD
Pindolol—Nausea—Ifosfamide—testicular cancer	0.0021	0.0021	CcSEcCtD
Pindolol—Diarrhoea—Cisplatin—testicular cancer	0.00209	0.00209	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—testicular cancer	0.00208	0.00208	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—testicular cancer	0.00207	0.00207	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Pindolol—Asthenia—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—testicular cancer	0.002	0.002	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Pindolol—Pruritus—Etoposide—testicular cancer	0.00198	0.00198	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—testicular cancer	0.00197	0.00197	CcSEcCtD
Pindolol—Vomiting—Cisplatin—testicular cancer	0.00194	0.00194	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Pindolol—Rash—Cisplatin—testicular cancer	0.00192	0.00192	CcSEcCtD
Pindolol—Dermatitis—Cisplatin—testicular cancer	0.00192	0.00192	CcSEcCtD
Pindolol—Diarrhoea—Etoposide—testicular cancer	0.00191	0.00191	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Pindolol—Flatulence—Epirubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Pindolol—Tension—Epirubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Pindolol—Nervousness—Epirubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Pindolol—Dizziness—Etoposide—testicular cancer	0.00185	0.00185	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Pindolol—Vertigo—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Pindolol—Nausea—Cisplatin—testicular cancer	0.00181	0.00181	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Pindolol—Vomiting—Etoposide—testicular cancer	0.00178	0.00178	CcSEcCtD
Pindolol—Rash—Etoposide—testicular cancer	0.00176	0.00176	CcSEcCtD
Pindolol—Dermatitis—Etoposide—testicular cancer	0.00176	0.00176	CcSEcCtD
Pindolol—Headache—Etoposide—testicular cancer	0.00175	0.00175	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Pindolol—Chest pain—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Pindolol—Myalgia—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Pindolol—Tension—Doxorubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Pindolol—Vertigo—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Pindolol—Syncope—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Pindolol—Palpitations—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Pindolol—Confusional state—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Pindolol—Nausea—Etoposide—testicular cancer	0.00166	0.00166	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—testicular cancer	0.00164	0.00164	CcSEcCtD
Pindolol—Myalgia—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Pindolol—Chest pain—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Pindolol—Anxiety—Epirubicin—testicular cancer	0.00163	0.00163	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—testicular cancer	0.00162	0.00162	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Pindolol—Syncope—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Pindolol—Confusional state—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Pindolol—Oedema—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Pindolol—Hypotension—Methotrexate—testicular cancer	0.00157	0.00157	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Pindolol—Shock—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Pindolol—Insomnia—Methotrexate—testicular cancer	0.00152	0.00152	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—testicular cancer	0.00149	0.00149	CcSEcCtD
Pindolol—Somnolence—Methotrexate—testicular cancer	0.00149	0.00149	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—testicular cancer	0.00147	0.00147	CcSEcCtD
Pindolol—Hypotension—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Pindolol—Oedema—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Pindolol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00145	0.00145	CcSEcCtD
Pindolol—Fatigue—Methotrexate—testicular cancer	0.00144	0.00144	CcSEcCtD
Pindolol—Pain—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Pindolol—Shock—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Pindolol—Insomnia—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Pindolol—Somnolence—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—testicular cancer	0.00137	0.00137	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Pindolol—Fatigue—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Pindolol—Pain—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Pindolol—Constipation—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Pindolol—Abdominal pain—Methotrexate—testicular cancer	0.00132	0.00132	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Pindolol—Constipation—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Pindolol—Pain—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Pindolol—Asthenia—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Pruritus—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Pindolol—Asthenia—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Pindolol—Pruritus—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Pindolol—Dizziness—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Pindolol—Diarrhoea—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Pindolol—Vomiting—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Pindolol—Rash—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Pindolol—Headache—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Pindolol—Dizziness—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Pindolol—Vomiting—Epirubicin—testicular cancer	0.000997	0.000997	CcSEcCtD
Pindolol—Nausea—Methotrexate—testicular cancer	0.000995	0.000995	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—testicular cancer	0.000992	0.000992	CcSEcCtD
Pindolol—Rash—Epirubicin—testicular cancer	0.000988	0.000988	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—testicular cancer	0.000988	0.000988	CcSEcCtD
Pindolol—Headache—Epirubicin—testicular cancer	0.000982	0.000982	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Pindolol—Nausea—Epirubicin—testicular cancer	0.000931	0.000931	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—testicular cancer	0.000922	0.000922	CcSEcCtD
Pindolol—Rash—Doxorubicin—testicular cancer	0.000915	0.000915	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Pindolol—Headache—Doxorubicin—testicular cancer	0.000909	0.000909	CcSEcCtD
Pindolol—Nausea—Doxorubicin—testicular cancer	0.000862	0.000862	CcSEcCtD
